These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Pulmonary hypertension following use of appetite depressants?]. Homann G Med Klin; 1974 Feb; 69(5):211. PubMed ID: 4819931 [No Abstract] [Full Text] [Related]
12. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B N Engl J Med; 1996 Aug; 335(9):609-16. PubMed ID: 8692238 [TBL] [Abstract][Full Text] [Related]
16. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. Mark EJ; Patalas ED; Chang HT; Evans RJ; Kessler SC N Engl J Med; 1997 Aug; 337(9):602-6. PubMed ID: 9271482 [No Abstract] [Full Text] [Related]
17. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for obesity -- do the benefits outweigh the risks? Manson JE; Faich GA N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523 [No Abstract] [Full Text] [Related]
19. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned? Voelkel NF; Clarke WR; Higenbottam T Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009 [No Abstract] [Full Text] [Related]
20. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium. Delcroix M; Kurz X; Walckiers D; Demedts M; Naeije R Eur Respir J; 1998 Aug; 12(2):271-6. PubMed ID: 9727773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]